Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on c h activation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112939780B details a robust Rh-catalyzed C-H activation route for indanone derivatives, offering high yields and simplified purification for API manufacturing.
Discover the scalable iron-catalyzed preparation of pyrrolo[1,2-a]indole alkaloids. A cost-effective, high-purity route for pharmaceutical intermediates.
Patent CN105646327A reveals a green Pd-catalyzed route for 2-perfluoroalkyl indoles. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Discover a novel one-step C-H activation method for 3-acylated indoles. This patent-pending route offers mild conditions and high yields for pharmaceutical intermediates.
Novel Rh-catalyzed route for anticancer sultams disclosed in CN113444107B. High atom economy, scalable process for pharmaceutical intermediates manufacturing.
Patent CN113511966B details a Rh-catalyzed route for trifluoromethyl dihydrophenanthrenes. Offers high yield, mild conditions, and scalable potential for pharmaceutical intermediate manufacturing.
Novel cobalt-catalyzed C-H carbonylation for indolo[1,2-a]quinazolin-6(5H)-ones. High efficiency, scalable route for pharmaceutical intermediates.
Novel rhodium-catalyzed method for trifluoromethyl enaminones offers high purity and scalable production for pharmaceutical intermediates supply chain efficiency and cost reduction.
Patent CN115286609B reveals a ruthenium-catalyzed route for high-purity pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability.
Novel rhodium-catalyzed method enhances trifluoromethyl enaminone production. Delivers high purity pharmaceutical intermediates with reduced costs and scalable supply chain reliability for global buyers.
Patent CN109879792B details a Rh(III)-catalyzed oxidative Heck reaction for isoindoles. Offers efficient route for pharma intermediates with reduced steps.
Patent CN118619879A reveals a novel Rhodium-catalyzed C-H activation route for trifluoromethyl enaminones, offering high purity and scalable pharmaceutical intermediate manufacturing.
Patent CN118619879A reveals Rh-catalyzed C-H activation for trifluoromethyl enaminones. Delivers high purity, cost efficiency, and scalable supply chain solutions for global pharmaceutical manufacturing.
Patent CN115925692A details a robust Rh-catalyzed route for trifluoromethyl enamines, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN113735756A details a novel Rh-catalyzed [4+1] cyclization for high-purity chiral isoindolinones, offering significant cost reduction in API manufacturing.
Novel Pd-catalyzed route for trifluoroacetyl indoline. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN114516880B details copper-catalyzed synthesis offering cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Novel Rh-catalyzed one-pot synthesis for indoloisoquinolines. Reduces steps, improves efficiency for pharmaceutical intermediates manufacturing and supply chain.
Patent CN113149895A reveals a Pd-catalyzed route to isoquinolones using alkenes. Discover cost-effective manufacturing and high-purity supply solutions.
Novel Rh-catalyzed route for high-purity benzo[1,8]naphthyridine compounds. Enhances supply chain reliability and cost efficiency for optoelectronic manufacturing.